AVIR
NASDAQ · Pharmaceuticals
Atea Pharmaceuticals Inc
$4.48
+0.00 (+0.00%)
Open$4.48
Previous Close$4.48
Day High$4.58
Day Low$4.43
52W High$6.45
52W Low$2.78
Volume—
Avg Volume266.5K
Market Cap348.92M
P/E Ratio—
EPS$-2.12
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+927.9% upside
Current
$4.48
$4.48
Target
$46.05
$46.05
$31.54
$46.05 avg
$64.23
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 49.99M | 49.26M | 44.69M |
| Net Income | 8.60M | 11.50M | 7.45M |
| Profit Margin | 17.2% | 23.3% | 16.7% |
| EBITDA | 12.90M | 12.92M | 13.20M |
| Free Cash Flow | 9.03M | 8.66M | 6.93M |
| Rev Growth | +19.5% | +7.9% | +2.0% |
| Debt/Equity | 0.36 | 0.36 | 0.32 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,117.26 | +0.92% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $241.00 | +0.80% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $120.60 | +0.84% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.04 | -2.75% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $78.17 | +1.73% | 12.5 | 33.00B |